Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial

Background: In the FULFIL trial, once-daily single-inhaler triple therapy with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) resulted in reduced moderate/severe exacerbation rates and conferred significant improvements in lung function and health status in patients with chronic obstructiv...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of chronic obstructive pulmonary disease Vol. 17; pp. 2043 - 2052
Main Authors:	Panettieri, Reynold A., Jr, Camargo, Carlos A., Jr, Cheema, Tariq, Bayadi, Sherif G.El, Fiel, Stanley, Vila, Tania M, Jain, Renu G, Midwinter, Dawn, Thomashow, Byron, Ludwig-Sengpiel, Andrea, Lipson, David A
Format:	Journal Article
Language:	English
Published:	London Dove Medical Press Limited 01-01-2022 Dove Medical Press Ltd Dove Dove Medical Press
Subjects:	Analysis Care and treatment Chronic obstructive pulmonary disease Clinical trials Confidence intervals copd exacerbations Generalized linear models Hospitalization ics/laba Inhalers Lung diseases, Obstructive Medical research Medicine, Experimental Original Research Patients Respiratory agents severe exacerbations triple therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!